Glaucoma at a New Velocity

In the Obstbaum Lecture during ASCRS Glaucoma Subspecialty Day, Steven R. Sarkisian Jr., MD, called for urgency in adopting interventional glaucoma and moving earlier to surgical care.

By: Steven R. Sarkisian, Jr., MD

Glaucoma Physician April 22, 2026

Clinical Report: Glaucoma at a New Velocity

Overview

Dr. Steven R. Sarkisian Jr. emphasizes the urgency of adopting interventional glaucoma surgery, advocating for earlier surgical intervention to prevent vision loss. His insights reflect a shift in the treatment paradigm towards recognizing glaucoma as a surgical disease.

Background

Glaucoma is a leading cause of irreversible blindness worldwide, making effective management crucial. Traditional treatment has focused on maximizing medical therapy before considering surgical options. Recent advancements in minimally invasive glaucoma surgery (MIGS) present opportunities for earlier intervention, potentially improving patient outcomes.

Data Highlights

No numerical data provided in the article.

Key Findings

Glaucoma should be recognized as a surgical disease requiring urgent intervention.
Dr. Sarkisian has been a pioneer in the development and adoption of MIGS techniques.
There is a need for safer surgical alternatives to traditional trabeculectomy to reduce risks of vision loss.
Physicians must adapt to new technologies to meet patient expectations and improve care.
Recent guidelines advocate for earlier procedural interventions in glaucoma management.

Clinical Implications

Suggest specific steps or resources for integrating MIGS into clinical practice.

Conclusion

The call for urgency in adopting interventional glaucoma strategies highlights a significant shift in treatment paradigms. By prioritizing surgical options, clinicians can better address the challenges posed by glaucoma.

PentaVision

Glaucoma Physician